MBIO.CSE
MindBio Therapeutics Corp

3
Loading...
Loading...
Mindbio Therapeutics Corp. engages in the provision of developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company was founded by Justin Hanka in 2020 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of MindBio Therapeutics Corp?
What is the 52-week high for MindBio Therapeutics Corp?
What is the 52-week low for MindBio Therapeutics Corp?
What is MindBio Therapeutics Corp stock price today?
What was MindBio Therapeutics Corp stock price yesterday?
What is the PE ratio of MindBio Therapeutics Corp?
What is the Price-to-Book ratio of MindBio Therapeutics Corp?
What is the 50-day moving average of MindBio Therapeutics Corp?

Latest MBIO.CSE News

View
No MBIO.CSE news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.